Ovid Therapeutics (OVID) Earnings Analysis
Ovid Therapeutics (OVID) next reports earnings on 2026-08-12, consensus EPS -0.1 USD. Last quarter (2026-03-18) it beat with EPS 0.06 USD vs -0.1 USD est (+160%). It has beaten estimates in 3/3 recent quarters (100%). Trailing P/E -6.88.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does OVID next report earnings?
| Next earnings date | 2026-08-12 |
|---|---|
| Consensus EPS estimate | -0.1 USD |
| Revenue estimate | 0.00B |
OVID earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-18 | 0.06 USD | -0.1 USD | +160% | Beat |
| 2025-08-13 | -0.06 USD | -0.16 USD | +62.5% | Beat |
| 2025-03-11 | -0.13 USD | -0.16 USD | +18.8% | Beat |
Beat rate: 3/3 (100%) over reported quarters with consensus data.
OVID valuation and analyst view
| Trailing P/E | -6.88 |
|---|---|
| Trailing EPS | -0.32775 USD |
| Price / book | 0.89 |
| Dividend yield | 0.00% |
| Market cap | 0.31B |
| Analyst consensus | Buy (11 buy / 3 hold / 0 sell) |
| Avg price target | 7 USD |
Related research pages
Frequently asked questions
When is Ovid Therapeutics (OVID)'s next earnings date?
Ovid Therapeutics is next scheduled to report on 2026-08-12, with a consensus EPS estimate of -0.1 USD and revenue estimate of 0.00B.
Did OVID beat earnings last quarter?
In its 2026-03-18 report, OVID posted EPS of 0.06 USD versus a -0.1 USD estimate — a beat of 160%.
What is OVID's earnings track record?
Over the last 3 reported quarters with consensus data, OVID beat estimates 3 times (100%).
What is OVID's current P/E ratio and EPS?
OVID trades at a trailing P/E of -6.88 on trailing EPS of -0.327752103915712 USD.
What do analysts rate OVID?
Analyst consensus is "Buy" across 14 ratings (0 strong buy, 11 buy, 3 hold, 0 sell, 0 strong sell). Average 12-month price target: 7 USD.